Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Livrea

Showing results (1-10 of 112) with videos related to

Pageof 12
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|February 9, 2002
Epidemiology of primary blepharospasmGiovanni Defazio, Paolo Livrea
Drugs|February 12, 2004
Primary blepharospasm: diagnosis and managementGiovanni Defazio, Paolo Livrea
Recent Patents on CNS Drug Discovery|January 29, 2008
Voltage-gated sodium channel blockers as immunomodulatorsFrancesco Roselli, Paolo Livrea, Emilio Jirillo
Journal of Neuroimmunology|September 3, 2004
Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patientsMaurizio Giorelli, Paolo Livrea, Maria Trojano
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 19, 2005
Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-betaMaurizio Giorelli, Paolo Livrea, Maria Trojano
Consciousness and Cognition|September 3, 2008
Aesthetic value of paintings affects pain thresholdsMarina de Tommaso, Michele Sardaro, Paolo Livrea
Plos One|August 11, 2011
CDK5 is essential for soluble amyloid β-induced degradation of GKAP and remodeling of the synaptic actin cytoskeletonFrancesco Roselli, Paolo Livrea, Osborne F X Almeida
CNS Drug Reviews|July 14, 2007
Glatiramer acetate in multiple sclerosis: a reviewMaddalena Ruggieri, Carlo Avolio, Paolo Livrea, et al.
The Lancet. Neurology|October 19, 2004
Epidemiology of primary dystoniaGiovanni Defazio, Giovanni Abbruzzese, Paolo Livrea, et al.
Experimental Neurology|March 6, 2007
Immunomodulatory properties of increased levels of liver X receptor beta in peripheral blood mononuclear cells from multiple sclerosis patientsMaurizio Giorelli, Paolo Livrea, Mauro Giuseppe Minervini, et al.
Pageof 12

Showing results (1-10 of 112) with videos related to

Sort By:
Pageof 12
Movement Disorders : Official Journal of the Movement Disorder Society|February 9, 2002
Epidemiology of primary blepharospasmGiovanni Defazio, Paolo Livrea
Drugs|February 12, 2004
Primary blepharospasm: diagnosis and managementGiovanni Defazio, Paolo Livrea
Recent Patents on CNS Drug Discovery|January 29, 2008
Voltage-gated sodium channel blockers as immunomodulatorsFrancesco Roselli, Paolo Livrea, Emilio Jirillo
Journal of Neuroimmunology|September 3, 2004
Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patientsMaurizio Giorelli, Paolo Livrea, Maria Trojano
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 19, 2005
Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-betaMaurizio Giorelli, Paolo Livrea, Maria Trojano
Consciousness and Cognition|September 3, 2008
Aesthetic value of paintings affects pain thresholdsMarina de Tommaso, Michele Sardaro, Paolo Livrea
Plos One|August 11, 2011
CDK5 is essential for soluble amyloid β-induced degradation of GKAP and remodeling of the synaptic actin cytoskeletonFrancesco Roselli, Paolo Livrea, Osborne F X Almeida
CNS Drug Reviews|July 14, 2007
Glatiramer acetate in multiple sclerosis: a reviewMaddalena Ruggieri, Carlo Avolio, Paolo Livrea, et al.
The Lancet. Neurology|October 19, 2004
Epidemiology of primary dystoniaGiovanni Defazio, Giovanni Abbruzzese, Paolo Livrea, et al.
Experimental Neurology|March 6, 2007
Immunomodulatory properties of increased levels of liver X receptor beta in peripheral blood mononuclear cells from multiple sclerosis patientsMaurizio Giorelli, Paolo Livrea, Mauro Giuseppe Minervini, et al.
Pageof 12